<SEC-DOCUMENT>0001062993-24-007170.txt : 20240327
<SEC-HEADER>0001062993-24-007170.hdr.sgml : 20240327
<ACCEPTANCE-DATETIME>20240327091809
ACCESSION NUMBER:		0001062993-24-007170
CONFORMED SUBMISSION TYPE:	FWP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240327
DATE AS OF CHANGE:		20240327

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		FWP
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-274686
		FILM NUMBER:		24786055

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		FWP

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>FWP
<SEQUENCE>1
<FILENAME>formfwp.htm
<DESCRIPTION>FORM FWP
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Form FWP - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: right;">Filed pursuant to Rule 433<br>Registration Statement No. 333-274686</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right;">Issuer Free Writing Prospectus dated March 27, 2024</p>
    <p style="margin-top: 0pt; text-align: right;">Relating to Prospectus dated October 6, 2023</p>
    <p style="text-align: center;"><img src="formfwpx001.jpg" style="width: 266px;" height="28"></p>
    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-variant: small-caps; font-size: 12pt;"><b>Term Sheet</b></font></p>
    <p style="margin-top: 0pt; text-align: center;"><font style="font-variant: small-caps; font-size: 12pt;"><b>Approximately $25 million Treasury Offering Of Equity Units</b></font><br><font style="font-variant: small-caps; font-size: 12pt;"><b>March 27, 2024</b></font></p>
    <p style="text-align: justify;"><i>The Units (as hereinafter defined) will be offered by way of a prospectus supplement to a final base shelf prospectus in each of the provinces and territories of Canada. A prospectus supplement containing important information relating to the Offered Shares has not yet been filed with the applicable Canadian securities regulatory authorities.</i></p>
    <p style="text-align: justify;"><i>A final base shelf prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in each of the provinces and territories of Canada, and a corresponding registration statement on Form F-10 (SEC File No.333-274686) has been filed with the United States Securities and Exchange Commission ("SEC"). A copy of the final base shelf prospectus, any amendment to the final base shelf prospectus and any applicable shelf prospectus supplement that has been filed, is required to be delivered with this document.</i></p>
    <p style="text-align: justify;"><i>This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the final base shelf prospectus, any amendment and any applicable shelf prospectus supplement for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.</i></p>
    <p style="text-align: justify;"><i>All amounts in Canadian dollars ($) except as otherwise stated.</i></p>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Issuer:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Organigram Holdings Inc. (the "<b>Company</b>").</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Amount:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">Approximately $25 million with an additional 15% over-allotment option (the "<b>Offering</b>").</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Issue:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">Treasury offering of 7,740,000 units of the Company (the "<b>Units</b>").</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Issue Price:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">$3.23 per Unit.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Units:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">Each Unit consists of one share of common stock of the Company (a "<b>Common Share</b>") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "<b>Warrant</b>").</p>
                <p style="text-align: justify;">The Warrants will contain a customary put feature in the event of a fundamental transaction based on the Warrants' Black-Scholes value.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Warrants:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Each Warrant will entitle the holder to acquire one Common Share from the Company at a price of $3.65 per Common Share for a period of 48 months following the Closing Date (as defined below).</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Over-Allotment Option:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">The Company has granted the Underwriter an option, exercisable at the Issue Price at any time up to 30 days following the closing of the offering, to purchase up to an additional 15% of the offering to cover overallotments, if any.</p>
            </td>
        </tr>
    </table>
    <p><img src="formfwpxu001.jpg"></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a><br>
    <table style="border-collapse: collapse; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Use of Proceeds:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">The Company intends to use the net proceeds of the Offering to fund growth initiatives and for general corporate purposes.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Listing:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">Application will be made to list the Common Shares on the TSX and on the Nasdaq Global Select Market Exchange (the "<b>NASDAQ</b>"). Listing will be subject to fulfilling all the listing requirements of the TSX and NASDAQ, respectively. The existing common shares of the Company are listed on the TSX under the symbol "<b>OGI</b>" and the NASDAQ under the symbol "<b>OGI</b>".</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Form of Offering:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt;">Public offering by way of a final base shelf prospectus and prospectus supplement filed in each of the provinces of Canada, and pursuant to the multijurisdictional disclosure system in the United States.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Eligibility:</b></p>
            </td>
            <td style="margin-bottom: 0pt; vertical-align: top; width: 80%;">
                <p style="text-align: justify; margin-top: 0pt;">Eligible for DPSPs, RDSPs, RESPs, RRIFs, RRSPs and TFSAs.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="margin-bottom: 0pt; vertical-align: top; width: 80%;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Lead Underwriter:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">ATB Securities Inc., and its affiliates (the "<b>Underwriter</b>").</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Commission:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">Cash commission equal to 4.75% of the gross proceeds of the Offering.</p>
            </td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">&#160;</td>
            <td style="width: 80%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 20%; vertical-align: top;">
                <p><b>Closing Date:</b></p>
            </td>
            <td style="width: 80%; vertical-align: top;">
                <p style="text-align: justify; margin-top: 0pt; margin-bottom: 0pt;">The closing of the Offering will be on or about April 2, 2024 (the "<b>Closing Date</b>").</p>
            </td>
        </tr>
    </table>
    <p style="text-align: justify;"><u><i>Notice prescribed by Rule 433 under the U.S. Securities Act of 1933</i></u></p>
    <p style="text-align: justify;"><i>The issuer has filed a registration statement (including a base shelf prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed or will file with the SEC, including the prospectus supplement, for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, a copy of the prospectus supplement, following filing thereof, the base shelf prospectus and the registration statement may also be obtained from ATB Securities Inc., 66 Wellington Street West, Suite 3530, Toronto, Ontario M5K 1A1, Attn: Jay Lewis, by telephone at +1 (647) 688-7077, or by email at ogi-prospectus@atb.com.</i></p>
    <p style="text-align: justify;">&#160;</p>
    <div>
        <p style="text-align: justify;"><img src="formfwpxu002.jpg"></p>
    </div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formfwpx001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formfwpx001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  < 0H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[(6ZAN([7
M[/)9POJ-N);$WL*R0SG S&QP"K D#@X(Z#.17FGCYG76)+:^T2VTV]B.'^R9
M6.3T;:<CGU&*B76WG\%MH=S@_99Q<6DF?F7)PR?3YMWX'VJI<:AJ&K>1:74C
MW4JD) [G=(,G[N>I'L>G:OI*&'=.3?0^5Q&*C5@EU_K3_*Q0KV+]GDG_ (1"
M[&>E\W_H"5P/B?P/K^A^4T\,<\<T@BC>!]V7/1<'!R?I7I7P2TN_TCPW=6NH
MV[03-=E]C$$@%$QG'TK+,*M.>']UW-LMHU(8KWHM:$WQ(\57NDW5CX?\/64=
M]XAU?=]DAE)$4$:_>FE(Y"#\R>!5.W^']_>J)_$OC?Q#>W3 EELKLV-NA/\
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MHX+O4;J.Z6X8IYB,S;2!D [O49Q]#74^(M;&J_ F.623,RRQVTO/)9"#S]0
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)JKRJ0:L['__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>formfwpxu001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formfwpxu001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
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M +5KZ#_:S\=?\('\"?$=Q%(8[R_C&FVY!YW2_*V/HF\_A7SY_P $U?O>-/\
MKWL?_:M>K_M<?!WQK\:YO"ND>'X;4:':3M<7TT]R(V#DA1A>^U-Y_P"!5\[F
M,,//BF/UN:C37LVV]K1IQ=OFTD>_@95H\/26'BY3?.DEYSDK_*[9\AZKJGAK
MP-X0^$6O^&M:M;OQ5I$LEQJEI 3YB,91,@;CL-R&O;/V\]0L]9L/A9J5B$-K
M>M+<1LH W(XA93Q[&O5_C1^R5X6\0_#"_P!.\&^&M+TSQ)&(FL[I$$3.5895
MG]&7=GWKRWQM^S3\3_%_PI^&>@RV.GG5?#,MS#<%K]=I@+H82#CD[05Q_LCU
MKW\-G&6XS$X3'NKRRISJI\[5^6<923TTY5)V7:]CQ:^5X_"T,1A/9\RG&FUR
M)VO%I/?JTKLL?\%$88XO#?@ QQHA-Q<YVJ!G]W'7FO[0&O>*?%>J>"T^*G@Y
M? WAZ&0K_:.EP">:6,A=PW;R#@#.W.1DG!QBOHG]L7X)>+/C%H?A.W\+VMO=
M3:;-,]PL]PL6 R(!C/7E37"^,O@?\<_C^='TGQQ-H/ASP_82"3%D_F/G;M+;
M06W-M) RP'-89'F&#H8#!NM5IKV;J\S<FJD%*]G!*]V_--;&^;8'%5<9B53I
MS?.J=DHKDE:U^9NUDO)H^O=%FM+C1;"73Y!-8/;QM;R*<AXRHVG/N,5^3$7_
M "%-;_[",_\ Z%7ZRZ!HMOX;T'3M)M PM;"VCMHMQR=B*%&?? K\FHO^0IK?
M_81G_P#0JY.![7QG+M[G_I4C3C&_)A>;?WORB>U_L%_$WPK\.!XI?Q/KMGHJ
MW<%F(/M3[?,VB3=CZ9'YU]<?\-0_"C_H>](_[^G_  K\GK3_ (](/^N:_P A
M4M?;X[@K!YO6^NU:LHRDHZ+EMI&*ZKR/E\'Q7B<LI?5:=.+47+5WOK)OH?JY
M_P -0_"C_H>](_[^G_"C_AJ'X4?]#WI'_?T_X5^4=%>?_P 0XR__ )_S_P#)
M?\CM_P!>L9_SYC_Y,?JY_P -0_"C_H>](_[^G_"C_AJ'X4?]#WI'_?T_X5^4
M=%'_ !#C+_\ G_/_ ,E_R#_7K&?\^8_^3'ZN?\-0_"@_\SWI'_?T_P"%?FS:
M3)<WVKS1.)(I+^9T<=&4MD$?A7$UU'A;_CPD_P"NI_D*]O+^&L/P_3JRH5)2
;Y^5.]NC?;U/&S#/JV=2IQJP4>6^U^MN_H?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>formfwpxu002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formfwpxu002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP
M("AU<VEN9R!)2D<@2E!%1R!V.3 I+"!Q=6%L:71Y(#T@.3 *_]L 0P # @(#
M @(# P,#! ,#! 4(!04$! 4*!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3
M%!45%0P/%Q@6%!@2%!44_]L 0P$#! 0%! 4)!04)% T+#104%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@
M*@ \ P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ ;^S/^S#:?M!1ZN@U.VT0Z7#;MDZ>L_F^8&_VEQC9[]:]S_X=
MF6W_ $.5K_X)%_\ CM-_X)J_>\:?]>]C_P"U:^X+BXCM+>6>9Q'%&I=W;HJ@
M9)K]3X@X@S'+\QEAL+-*"4++D@]X1?6+>[/SK)<EP.-P,<1B(MR;E=\TEM*7
M:5MCXA_X=F6W_0Y6O_@D7_X[1_P[,MO^ARM?_!(O_P =KUGP1^VWX1\?>*5T
M'3M'U=;R6.=[=IEC"SM&C.$7Y\[G"D+GN17/-_P4-\%(!O\ #7B%">S11#_V
M>JCB>,)3=-4WS))VY*6SO;IY/[A.APPH*;FK.ZOSU-UOU\SA_P#AV9;?]#E:
M_P#@D7_X[1_P[,MO^ARM?_!(O_QVNX;_ (*&^"H\;O#?B%<]-T40_P#9ZV/"
MW[>?P\\0:S;Z=>VVK:"9W")<W\">2I)P-Q5B5'OC%5.OQE3BYRI.R_Z=TW^2
M;_ 4*/"\Y*,:BN_[\_U9Y?\ \.S+7_H<K;_P2+_\=KY9TKP[863ZA:M96DQM
M[N2'>;=.=N!GIQTK]APP9<@@@C(([U^1<7_(4UO_ +",_P#Z%7L<+9MB\WCB
M%C6I<O);W8JUW*^T5V/(XER[#98Z+PB<>;FO[TGLEW;/I'_@FK][QI_U[V/_
M +5KZ#_:S\=?\('\"?$=Q%(8[R_C&FVY!YW2_*V/HF\_A7SY_P $U?O>-/\
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;Y^5.]NC?;U/&S#/JV=2IQJP4>6^U^MN_H?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
